Brief: Cellistic To Acquire Celyad Oncology's Manufacturing Business Unit For EUR 6 Mln

Celyad Oncology SA

20/09/2022 06:12

Sept 20 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELLISTIC AND CELYAD ONCOLOGY ANNOUNCE GMP CELL THERAPY
MANUFACTURING OPERATIONS TRANSACTION
    * CELLISTIC WILL ACQUIRE CELYAD ONCOLOGY'S GOOD
MANUFACTURING
PRACTICE (GMP) GRADE CELL THERAPY MANUFACTURING CAPABILITY
    * CELLISTIC AGREED TO ACQUIRE CELYAD ONCOLOGY'S
MANUFACTURING
BUSINESS UNIT IN MONT-SAINT-GUIBERT, BELGIUM, FOR A TOTAL
CONSIDERATION OF EUR 6 MILLION
    * TRANSACTION IS ANTICIPATED TO CLOSE IN Q4 OF THIS YEAR

Source text for Eikon:  ID:nGNX2tT2S3 
Further company coverage:  CYAD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))